Incyte (INCY) FCF Margin (2010 - 2026)
Incyte posted quarterly FCF Margin of 28.22% for Q1 2026, up 325.0% year-on-year from 6.64% in Q1 2025, and down 12.97% on a QoQ basis from 32.43% in Q4 2025.
Incyte (INCY) has 17 years of FCF Margin data on file, last reported at 28.22% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 325.0% year-over-year to 28.22%; the trailing twelve-month figure through Mar 2026 stood at 27.06% (up 1852.0% YoY), and the FY2025 full-year result was 26.35%, up 1850.0% from the prior year.
- FCF Margin for Q1 2026 stood at 28.22%, down from 32.43% in the prior quarter.
- Across five years, FCF Margin topped out at 40.94% in Q3 2025 and bottomed at 55.18% in Q2 2024.
- The 5-year median for FCF Margin is 27.08% (2024), against an average of 18.8%.
- The widest annual swing landed in 2024, when FCF Margin sank 8652 bps; it then surged 5879 bps in 2025.
- A 5-year view of FCF Margin shows it stood at 36.34% in 2022, then sank by 69 bps to 11.37% in 2023, then jumped by 185 bps to 32.42% in 2024, then advanced by 0 bps to 32.43% in 2025, then decreased by 13 bps to 28.22% in 2026.
- The last three FCF Margin figures came in at 28.22% (Q1 2026), 32.43% (Q4 2025), and 40.94% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4.17% |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 28.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.22% |
| Dec 31, 2025 | 32.43% |
| Sep 30, 2025 | 40.94% |
| Jun 30, 2025 | 3.61% |
| Mar 31, 2025 | 24.97% |
| Dec 31, 2024 | 32.42% |
| Sep 30, 2024 | 27.08% |
| Jun 30, 2024 | -55.18% |
| Mar 31, 2024 | 24.80% |
| Dec 31, 2023 | 11.37% |
| Sep 30, 2023 | 18.18% |
| Jun 30, 2023 | 31.34% |
| Mar 31, 2023 | -14.53% |
| Dec 31, 2022 | 36.34% |
| Sep 30, 2022 | 32.62% |
| Jun 30, 2022 | 17.68% |
| Mar 31, 2022 | 27.27% |
| Dec 31, 2021 | 27.21% |
| Sep 30, 2021 | 27.42% |
| Jun 30, 2021 | 11.31% |
| Mar 31, 2021 | 30.57% |
| Dec 31, 2020 | 12.33% |
| Sep 30, 2020 | 29.66% |
| Jun 30, 2020 | 42.71% |
| Mar 31, 2020 | -127.12% |
| Dec 31, 2019 | 28.93% |
| Sep 30, 2019 | 52.07% |
| Jun 30, 2019 | 19.94% |
| Mar 31, 2019 | 27.60% |
| Dec 31, 2018 | 23.54% |
| Sep 30, 2018 | 38.77% |
| Jun 30, 2018 | 4.14% |
| Mar 31, 2018 | 2.16% |
| Dec 31, 2017 | -42.67% |
| Sep 30, 2017 | 24.59% |
| Jun 30, 2017 | 26.43% |
| Mar 31, 2017 | -50.67% |
| Dec 31, 2016 | 27.68% |
| Sep 30, 2016 | 65.34% |
| Jun 30, 2016 | -26.25% |
| Mar 31, 2016 | 34.91% |
| Dec 31, 2015 | 27.06% |
| Sep 30, 2015 | -3.00% |
| Jun 30, 2015 | 6.87% |
| Mar 31, 2015 | -5.11% |
| Dec 31, 2014 | 35.22% |
| Sep 30, 2014 | 6.22% |
| Jun 30, 2014 | -23.35% |
| Mar 31, 2014 | -38.26% |
| Dec 31, 2013 | -29.59% |
| Sep 30, 2013 | -14.97% |
| Jun 30, 2013 | 7.40% |
| Mar 31, 2013 | 33.55% |
| Dec 31, 2012 | -20.15% |
| Sep 30, 2012 | -45.54% |
| Jun 30, 2012 | 8.92% |
| Mar 31, 2012 | -151.74% |
| Dec 31, 2011 | -141.13% |
| Sep 30, 2011 | -286.96% |
| Jun 30, 2011 | -189.23% |
| Mar 31, 2011 | -140.04% |
| Dec 31, 2010 | 28.72% |
| Sep 30, 2010 | -177.74% |
| Jun 30, 2010 | -6.75% |
| Mar 31, 2010 | 593.00% |